MitraClip implantation may serve as a viable bridge to elective mitral valve replacement in patients with ischemic papillary muscle rupture.
Answers are grounded in this paper and cite their sources.
MitraClip may bridge to elective replacement after papillary muscle rupture; hypothesis-generating case leaves role unproven.
MitraClip implantation has been reported in severe mitral regurgitation following ischemic papillary muscle rupture in surgically high-risk patients with cardiogenic shock. Here we present a case of a 68-year-old female patient who suffered an ischemic papillary muscle rupture resulting in severe mitral prolapse and had a MitraClip implanted. Three months later, due to progressive symptoms, she was taken to surgery and had an elective minimally invasive mitral valve replacement. Informed consent was given and ethics board approval was obtained.
No takes yet. Share an insight, caveat, or question.
Vinck et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: